Helixmith
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 11/14/2021
Pipeline by Phase
Therapeutic Focus
Clinical Trials (15)
Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Started: 2/4/2019
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
Started: 11/20/2020
A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy
Started: 5/17/2021
Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers
Started: 6/27/2017
Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Started: 4/1/2016
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Started: 7/9/2010
Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
Started: 3/9/2021
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
Started: 8/1/2012
A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis
Started: 11/14/2021
The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19
Started: 5/6/2021
Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
Started: 1/25/2018
Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
Started: 3/11/2014
The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)
Started: 9/21/2020
Gene Therapy for the Treatment of Chronic Stable Angina
Started: 3/1/2015